HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CP 471,474

structure in first source

Also Known As:

CP-471,474

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Phenyl Ethers: 8
        Halogenated Diphenyl Ethers: 385
        CP 471,474: 1
- Ethers: 242
  - Phenyl Ethers: 8
    - Halogenated Diphenyl Ethers: 385
      - CP 471,474: 1

Experts

1.	Cisneros-Lira, José: 1 article (05/2003)
2.	Gaxiola, Miguel: 1 article (05/2003)
3.	Kudlacz, Elizabeth M: 1 article (05/2003)
4.	Mitchell, Peter G: 1 article (05/2003)
5.	Pardo, Annie: 1 article (05/2003)
6.	Ramírez, Remedios: 1 article (05/2003)
7.	Selman, Moisés: 1 article (05/2003)

Related Diseases

1.	Inflammation (Inflammations) 05/01/2003 - "CP-471,474 significantly reduced both the extent (p < 0.002) and severity (p < 0.05) of inflammation at 2 months. "
2.	Emphysema 05/01/2003 - "To evaluate the effect of CP-471,474 (Pfizer Global Research and Development; Groton, CT), a broad-spectrum inhibitor of matrix metalloproteinases (MMPs) in an experimental model of emphysema. "

Related Drugs and Biologics

1.	Matrix Metalloproteinases (MMPs)